NewLink Genetics raises $17M for cancer vaccine, drugs
NewLink Genetics, an Ames, Iowa, biotech working on cancer vaccines and drugs that modulate the immune system, has so far raised about $17 million in a third funding round. The company aims to raise another $8 million in the round for a total of $25… Continue Reading
Life sciences briefing: Thursday, Jan. 31, 2007
TODAY’S HEADLINES:
5AM Ventures puts $3.3M into stealthy ImmunoNewco (VBLS exclusive)
NewLink Genetics raises $17M for cancer vaccine, immune drugs (VBLS exclusive)
Biochip, stem-cell biotech Minerva Bio ousts CEO Jim Czirr and sues (release)
Sonexa Therapeutics takes $30M for Alzheimer’s treatment (release)
Tissue regenerator Healionics pulls in $1.7M (release)
EGeen, clinical… Continue Reading